6:18 PM
 | 
Jan 02, 2013
 |  BC Extra  |  Financial News

Heart Metabolics closes series A tranche

Heart Metabolics Ltd. (London, U.K.) raised $4 million in the first tranche of a planned $6 million series A round. Trans Tasman Commercialization Fund led the tranche, with participation from AshHill Investments. Additionally, Heart Metabolics hired Peter Milner as CEO and a director. Milner is a co-founder of Armetheon...

Read the full 232 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >